Good evening and welcome to Markets Desk, your close of business briefing for Monday, June eighth.
OpenAI made it official today, filing its confidential S-one registration with the SEC, the first formal step toward what could be a trillion-dollar public debut. But management was careful to temper expectations, noting it may be a while before the company actually lists, citing structural moves that are simply easier to execute while private. The filing lands in a crowded moment, with SpaceX expected to go public later this week and Anthropic having filed just days ago, making this a genuinely historic stretch for AI capital markets.
Turning to pharma, Eli Lilly announced three infectious disease acquisitions in a single day, a striking signal that the company is actively building its next growth engine beyond the blockbuster obesity franchise. Prevention and infectious disease represent a vast and underserved market, and Lilly clearly has the balance sheet firepower to pursue it aggressively after years of GLP-one driven revenue.
And in equities, Apple closed down nearly two percent at three hundred one dollars and fifty-four cents, even after briefly touching three hundred seventeen during its Worldwide Developers Conference. Investors got their first look at a next-generation AI-powered Siri and the updated Apple Intelligence platform, but the initial enthusiasm faded as traders weighed whether the features justify near-term multiple expansion.
That's the tape. Markets Desk, signing off the floor.
